{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:16:30Z","timestamp":1783646190921,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bioorg.2022.106206","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T11:05:59Z","timestamp":1666004759000},"page":"106206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of novel dihydropyrazole-stilbene derivatives for ameliorating heart failure through modulation of p38\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"129","author":[{"given":"Zhigang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-2844","authenticated-orcid":false,"given":"Xiaoxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.106206_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hfc.2016.07.001","article-title":"Understanding heart failure","volume":"13","author":"Mazurek","year":"2017","journal-title":"Heart Fail Clin."},{"key":"10.1016\/j.bioorg.2022.106206_b0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.17219\/acem\/103669","article-title":"Advanced heart failure: a review","volume":"28","author":"Kepinska","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.bioorg.2022.106206_b0020","doi-asserted-by":"crossref","unstructured":"S. Murthy, H.I. Lipman, Management of end-stage heart failure, Prim Care, 38 (2011) 265-276, viii.","DOI":"10.1016\/j.pop.2011.03.007"},{"key":"10.1016\/j.bioorg.2022.106206_b0025","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2022.106206_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.bioorg.2022.106206_b0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2022.106206_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108185","article-title":"Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines","volume":"238","author":"Tsutsui","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2022.106206_b0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bioorg.2022.106206_b0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ejhf.2397","article-title":"Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction","volume":"24","author":"Tomasoni","year":"2022","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.bioorg.2022.106206_b0060","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.121.053659","article-title":"Dapagliflozin and recurrent heart failure hospitalizations in heart failure with reduced ejection fraction: an analysis of DAPA-HF","volume":"143","author":"Jhund","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bioorg.2022.106206_b0065","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2020.08.031","article-title":"Targeting cyclic guanosine monophosphate to treat heart failure: JACC Review Topic of the Week","volume":"76","author":"Emdin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.bioorg.2022.106206_b0075","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Committees, angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.bioorg.2022.106206_b0080","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2022.106206_b0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0090","doi-asserted-by":"crossref","first-page":"e008410","DOI":"10.1161\/CIRCHEARTFAILURE.120.008410","article-title":"Association between angiotensin receptor-neprilysin inhibition, cardiovascular biomarkers, and cardiac remodeling in heart failure with reduced ejection fraction","volume":"14","author":"Murphy","year":"2021","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.bioorg.2022.106206_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.654051","article-title":"LCZ696 attenuated doxorubicin-induced chronic cardiomyopathy through the TLR2-MyD88 complex formation","volume":"9","author":"Ye","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2022.106206_b0100","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"Abeta amyloid pathology affects the hearts of patients with alzheimer's disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664457","article-title":"Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction","volume":"12","author":"Kologrivova","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.bioorg.2022.106206_b0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10741-019-09875-1","article-title":"Various aspects of inflammation in heart failure","volume":"25","author":"Dutka","year":"2020","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bioorg.2022.106206_b0120","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10741-021-10156-z","article-title":"Multiple roles of cardiac macrophages in heart homeostasis and failure","volume":"27","author":"Moskalik","year":"2022","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bioorg.2022.106206_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.106206_b0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bioorg.2022.106206_b0135","doi-asserted-by":"crossref","first-page":"e99495","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2022.106206_b0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bioorg.2022.106206_b0145","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect Biol."},{"key":"10.1016\/j.bioorg.2022.106206_b0150","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1159\/000356602","article-title":"Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK\/NFkappaB pathway in H9c2 cardiac cells","volume":"32","author":"Guo","year":"2013","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2022.106206_b0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2018.05.033","article-title":"Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents","volume":"154","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106206_b0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ejmech.2019.07.033","article-title":"Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors","volume":"180","author":"Boccellino","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106206_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113396","article-title":"Synthesis and in vivo screening of isosteviol derivatives as new cardioprotective agents","volume":"219","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106206_b0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd.2016.89","article-title":"Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease","volume":"15","author":"Gourdie","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.106206_b0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2022.106206_b0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bioorg.2022.106206_b0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2022.106206_b0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.bioorg.2022.106206_b0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bioorg.2022.106206_b0200","first-page":"198","article-title":"Neutrophil-macrophage cross-talk in acute myocardial infarction","volume":"38","author":"Frodermann","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2022.106206_b0205","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/eurheartj\/ehr434","article-title":"Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1beta synthesis","volume":"33","author":"Szardien","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2022.106206_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113743","article-title":"Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-Thiazole derivatives with anti-inflammatory activities for the treatment of sepsis","volume":"225","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106206_b0215","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/1568026620999200917153856","article-title":"2,4,5-trisubstituted thiazole: a privileged scaffold in drug design and activity improvement","volume":"20","author":"Zhang","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106206_b0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2019.10.411","article-title":"iNOS as a metabolic enzyme under stress conditions","volume":"146","author":"Anavi","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bioorg.2022.106206_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216622","article-title":"An investigation into the interaction between double hydroxide-based antioxidant benzophenone derivatives and cyclooxygenase 2","volume":"26","author":"Qiao","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2022.106206_b0230","doi-asserted-by":"crossref","first-page":"6699054","DOI":"10.1155\/2021\/6699054","article-title":"Alleviation of inflammation and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via IL-6\/STAT3 inhibition by raloxifene","author":"Huo","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bioorg.2022.106206_b0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2011.10.482","article-title":"NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach","volume":"52","author":"Octavia","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2022.106206_b0240","doi-asserted-by":"crossref","first-page":"e016862","DOI":"10.1161\/JAHA.120.016862","article-title":"Extracellular superoxide dismutase is associated with left ventricular geometry and heart failure in patients with cardiovascular disease","volume":"9","author":"Li","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bioorg.2022.106206_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101760","article-title":"SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis","volume":"37","author":"Hwang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2022.106206_b0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bioorg.2022.106206_b0255","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","volume":"533","author":"Zhao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:56Z","timestamp":1758617216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822006125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":51,"alternative-id":["S0045206822006125"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106206","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel dihydropyrazole-stilbene derivatives for ameliorating heart failure through modulation of p38\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106206"}}